Explanatory variable | Lineage 2 n = 67 (45.58%) | Non-lineage 2 n = 80 (54.42%) | Univariate regression: associations withM. tuberculosislineage 2 | Multivariate regression: associations withM. tuberculosislineage 2 | ||
---|---|---|---|---|---|---|
 |  |  | Crude OR (95% CI) | p-value | Adj. OR (95% CI) | p-value |
Study site n (%) | Â | Â | Â | Â | Â | Â |
Goroka* | 23 (34.33) | 15 (18.75) | Â | Â | Â | Â |
Alotau | 27 (40.30) | 5 (6.25) | 3.5 (1.11 - 11.18) | 0.033 | 3.3 (1.0 - 10.8) | 0.047 |
Madang | 17 (25.37) | 0 (75.00) | 0.2 (0.08 - 0.43) | <0.001 | 0.2 (0.1 - 0.4) | <0.001 |
Sex, n (%) | 31 (46.27) | 37 (46.25) | 1 (0.52 - 1.91) | 0.99 | Â | Â |
Men* | 36 (53.73) | 43 (53.75) | Â | Â | Â | Â |
Women | Â | Â | Â | Â | Â | Â |
Age - median years [IQR] | 30 [25-42] | 29 [22-40] | 1 [0.99 - 1.05] | 0.13 | 1.0 [0.98 - 1.1] | 0.218 |
HIV status | Â | Â | Â | Â | Â | Â |
Negative* | 19 (63.33) | 44 (95.65) | 12.74 (2.57 - | Â | Â | Â |
Positive | 11 (36.67) | 2 (4.35) | 63.07) | 0.002 | Â | Â |
TB treatment history, n (%) | Â | Â | Â | Â | Â | Â |
No* | 55 (91.67) | 66 (86.84) | Â | Â | Â | Â |
Yes | 15 (11.03) | 10 (13.16) | 0.60 (0.19 - 1.86) | 0.38 | Â | Â |
Drug resistance (any type) | Â | Â | Â | Â | Â | Â |
No* | 54 (83.08) | 72 (92.31) | Â | Â | Â | Â |
Yes | 11 (16.92) | 6 (7.69) | 2.44 (0.85 - 7.02) | 0.097 | 2.5 (0.7 - 8.5) | 0.153 |